Candice Meyer
Obstetrics & Gynecology · Tulsa, OKNPI 1437412087
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 184 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 37 manufacturers reported payments, led by AbbVie at 26.4% of the total. Reporting peaked in 2022 at $969 and has fallen 74.9% since, to $243 in 2025.
Across 184 payments — averaging $19.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$943
- Sumitomo Pharma America, Inc.$268
- Therapeuticsmd, Inc.$248
- Pfizer$207
- Organon$198
- Myovant Sciences Inc.$161
- plus $2K from 31 others
What the payments were for
- Food & beverage$3,567100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 60 | $943 |
| Sumitomo Pharma America, Inc. | 11 | $268 |
| Therapeuticsmd, Inc. | 15 | $248 |
| Pfizer | 11 | $207 |
| Organon | 9 | $198 |
| Myovant Sciences Inc. | 8 | $161 |
| Astellas Pharma US Inc | 6 | $143 |
| Millicent US Inc | 7 | $136 |
| AMAG Pharmaceuticals, Inc. | 1 | $119 |
| Exeltis, USA Inc. | 6 | $107 |
| Hologic Sales And Service, LLC | 5 | $90 |
| Gynesonics, Inc. | 1 | $89 |
| Mayne Pharma Commercial LLC | 4 | $85 |
| Minerva Surgical, Inc | 2 | $73 |
| Merck | 5 | $67 |
| Evofem Biosciences, Inc. | 4 | $66 |
| Bayer | 3 | $64 |
| Intuitive Surgical | 1 | $61 |
| Mylan Pharmaceuticals Inc. | 3 | $48 |
| Scynexis, Inc. | 3 | $47 |
| Sage Therapeutics, LLC | 2 | $38 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $38 |
| Vertex | 1 | $29 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Coopersurgical, Inc. | 1 | $25 |
| BD | 1 | $22 |
| Molnlycke Health Care US, LLC | 1 | $20 |
| Innovation Technologies Inc | 1 | $20 |
| Avion Pharmaceuticals | 1 | $20 |
| Mission Pharmacal Company | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| Convatec Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| Exact Sciences | 1 | $13 |
| Baxter Healthcare | 1 | $13 |
| Acessa Health Inc. | 1 | $12 |
| Meditrina | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTRAROSA$119
How this compares
$3,567 in reported general payments places this provider in the 75th percentile of 396 obstetrics & gynecology providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 25 | $434 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Tulsa
- Joseph NemcokTulsa$632K
- Jay WilliamsonTulsa$130K
- Lori HubbardTulsa$41K
- Micah RelicTulsa$20K
- Bryan RoehlTulsa$15K
- Timmeni StevensTulsa$14K
- Rachel GibbsTulsa$12K
- Thomas LaneTulsa$11K
- Carlos GuevaraTulsa$11K
- David CameronTulsa$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.